The use of the phthalate softener DEHP in PVC medical devices can pose a health risk to newly-born babies, an EU scientific committee said this week. The findings turn the spotlight back onto the controversial chemical and have been welcomed by health campaigners.
But in a report delivered on Monday the committee repeated an earlier refusal to suggest a tolerable daily intake (TDI) level for DEHP from medical devices - a pre-requisite for any future EU controls based on limiting the leaching of the substance from the polymer.
Please enter your details
Not a subscriber?
Take a free trial now to discover the critical insights and updates our coverage offers subscribers.